How Alzheimer’s Disease Affects Cell Communication

Alzheimer’s disease sabotages the brain’s communication systems at virtually every level, from the chemical signals that pass between individual neurons to the support networks of surrounding cells and even the blood vessels that feed them. The damage is not a single broken wire but a cascade of failures: toxic protein fragments hijack the receptors neurons use to talk to each other, immune cells that should protect the brain start destroying its connections, and misfolded proteins travel from cell to cell like a slow-spreading infection. Understanding these overlapping breakdowns helps explain why the disease is so difficult to treat and why its symptoms go far beyond simple memory loss.

How Synapses Start to Fail

The most immediate way Alzheimer’s disrupts cell communication is at the synapse, the tiny gap where one neuron releases chemical signals and another neuron receives them. In a healthy brain, a molecule called glutamate carries the majority of excitatory messages. It lands on receptors, particularly NMDA and AMPA receptors, and the receiving neuron fires or strengthens the connection for future use. Amyloid-beta, the sticky protein fragment that accumulates in Alzheimer’s brains, directly interferes with this process. Clumps of amyloid-beta (called oligomers) cause NMDA and AMPA receptors to be pulled off the surface of the receiving neuron and swallowed back inside the cell, weakening the signal.

At the same time, amyloid-beta activates a different set of NMDA receptors located outside the synapse. These “extrasynaptic” receptors are normally quiet, but when amyloid-beta switches them on, they flood the neuron with calcium and trigger a chain of harmful events, including tau phosphorylation, activation of cell-death enzymes, and the loss of dendritic spines where connections form.¹ The result is a double hit: the useful receptors at the synapse are removed while the damaging receptors outside the synapse are ramped up.² Memantine, one of the few drugs approved for moderate-to-severe Alzheimer’s, works by selectively blocking those extrasynaptic NMDA receptors while largely sparing the synaptic ones.³

Amyloid-beta also undermines synaptic communication through a less obvious route. It binds to a receptor called EphB2, which normally helps stabilize NMDA receptors at the synapse, and tags it for destruction. When EphB2 levels drop, NMDA receptor signaling weakens further and the neuron’s ability to strengthen connections in response to experience diminishes. In mouse models, restoring EphB2 levels rescued learning and memory, suggesting this pathway matters beyond the lab bench.⁴

The Cholinergic System Breaks Down

While glutamate handles most fast signaling in the brain, another neurotransmitter, acetylcholine, plays a critical role in attention, memory encoding, and the fine-tuning of neural circuits. The neurons that produce acetylcholine are clustered in a deep brain structure called the nucleus basalis of Meynert, and they send long projections into the hippocampus, amygdala, and cortex. In Alzheimer’s disease these neurons are devastated. Autopsy studies show roughly half of them are lost, and the survivors are shrunken, suggesting they are already failing before they die.⁵ The enzymes needed to manufacture and break down acetylcholine are measurably reduced in the hippocampus and cortex. This “cholinergic deficit” was one of the earliest biochemical findings in Alzheimer’s research and led to the development of cholinesterase inhibitors like donepezil, which boost whatever acetylcholine the remaining neurons can still produce.

Losing acetylcholine does not just dim memory circuits. It also removes a modulatory brake on inflammation and changes how cortical neurons respond to incoming signals. The cholinergic system is essentially a volume knob for attention and plasticity; when it fails, the entire cortex becomes noisier and less precise.

When the Brain’s Immune Cells Turn on Synapses

Neurons do not operate alone. They are surrounded by microglia, the brain’s resident immune cells, which constantly survey their environment and help maintain healthy connections. During normal development, microglia prune excess synapses using a tagging system borrowed from the immune complement cascade. A protein called C1q marks certain synapses, complement component C3 amplifies the signal, and microglia engulf the tagged connection through a receptor called CR3. This pruning is essential for a young brain to wire itself efficiently. In Alzheimer’s disease, the same system reactivates inappropriately.

Mouse studies showed that C1q accumulates at synapses well before amyloid plaques become visible, and that soluble amyloid-beta oligomers are sufficient to trigger this accumulation. When researchers blocked C1q, C3, or the CR3 receptor, the number of microglia actively eating synapses dropped and early synapse loss was reduced.⁶ Complement-tagged synapses also activate local cell-death-like machinery, meaning the synapse may already be weakened before microglia arrive to finish it off.⁷

Complement pruning is only part of the inflammatory picture. When microglia become chronically activated, they shift into an inflammatory state and release a cocktail of signaling molecules, including inflammatory cytokines like IL-1β, IL-6, and TNF-α. Prolonged exposure to these cytokines disrupts the molecular machinery neurons rely on to strengthen or weaken their connections, a process called synaptic plasticity.⁸ TNF-α in particular has a complex relationship with synaptic change: at normal levels it helps maintain a kind of homeostatic balance, but when microglia flood the area with it, the feedback mechanism tips from protective to destructive.⁹ The net effect is that the brain loses its ability to adapt its connections in response to experience, which is a cellular explanation for why learning new information becomes so difficult in Alzheimer’s.

How Tau Spreads from Neuron to Neuron

While amyloid-beta tends to accumulate in the spaces between cells, tau, the other hallmark protein of Alzheimer’s, builds up inside neurons. In its normal state tau stabilizes the internal scaffolding (microtubules) that neurons depend on for structure and transport. When tau becomes abnormally modified, it detaches from microtubules, clumps together, and forms the neurofibrillary tangles visible under a microscope. But tau pathology does not stay confined to one neuron. It spreads through the brain in a stereotypical pattern, moving from the entorhinal cortex into the hippocampus and eventually across the cortex, and this spread correlates tightly with symptom progression.

One route of transmission involves exosomes, small membrane-enclosed vesicles that neurons release and neighboring neurons take up. Using devices that culture two separate populations of connected neurons, researchers showed that tau packaged inside exosomes travels from one neuron’s axon terminal across the synapse and into the next neuron’s cell body. This transfer depends on actual synaptic connections; disconnected neurons do not pick up the tau-carrying vesicles.¹⁰ Tau seeds also travel in a “naked” form, as free-floating oligomers and small fibrils, and both forms can trigger misfolding of healthy tau in the receiving cell.¹¹

Beyond exosomes, cells can build thin membrane tubes, called tunneling nanotubes, that directly bridge two cells and allow the exchange of organelles, ions, and toxic protein aggregates. These structures have been shown to carry misfolded proteins associated with Alzheimer’s, Parkinson’s, and other neurodegenerative diseases, offering yet another way pathology can bypass the extracellular space and spread through connected circuits.¹²

Astrocytes and the Glial Support Network

Astrocytes, the star-shaped support cells that outnumber neurons in many brain regions, are deeply involved in synaptic communication. They wrap around synapses, mop up excess glutamate, supply neurons with energy substrates, and regulate the fluid and ion balance of the surrounding tissue. Researchers now describe the synapse as a “tripartite” structure: presynaptic neuron, postsynaptic neuron, and astrocyte, all working together.¹³ When any leg of this triad malfunctions, the whole synapse suffers.

In Alzheimer’s, amyloid-beta prods astrocytes into releasing glutamate themselves, which spills into the extrasynaptic space and activates those harmful extrasynaptic NMDA receptors on nearby neurons. This astrocyte-driven glutamate release was shown to depend on nicotinic acetylcholine receptors on the astrocyte surface, linking the amyloid and cholinergic problems into a single toxic loop.¹⁴

Astrocytes also communicate with each other through gap junctions, physical channels made of a protein called connexin-43 that bridge neighboring cells and allow ions, small molecules, and metabolic fuel to flow between them. This interconnected glial network is essential for distributing energy and buffering ions across large brain areas. In Alzheimer’s, connexin-43 function becomes abnormal, disrupting ion balance, metabolic support, and signaling across the glial network.¹⁵ Because neurons depend on astrocytes for glucose-derived lactate and for potassium clearance after firing, a sick astrocyte network means neurons are starved and bathing in excess ions even before plaques and tangles have done their worst.

Broken Transport Inside Neurons

Neurons are unlike most cells because they have extremely long projections. A cortical neuron’s axon can stretch centimeters, and it depends on a constant supply chain to ferry mitochondria, vesicles of neurotransmitter, and signaling molecules from the cell body to the synapse and back. Motor proteins like kinesin walk along microtubule tracks to carry these cargoes, and tau normally stabilizes those tracks. When tau is hyperphosphorylated and detaches in Alzheimer’s disease, microtubules become unstable and kinesin-1 transport is disrupted.¹⁶ Without functioning transport, synaptic terminals run out of neurotransmitter vesicles, mitochondria cannot reach the places where energy demand is highest, and waste products accumulate.

Calcium handling inside the neuron is also thrown off. The endoplasmic reticulum, a large internal membrane network, serves as the main calcium warehouse. Mutations linked to familial Alzheimer’s cause calcium to build up excessively inside this warehouse. Neurons initially try to compensate by adjusting their calcium-release channels, but over time these compensatory changes become toxic, contributing to synaptic dysfunction and cell death.¹⁷ Since calcium is the fundamental trigger for neurotransmitter release at the synapse, even subtle disruptions in its regulation ripple outward into degraded communication.

Loss of Growth Signals That Keep Synapses Alive

Neurons rely on growth factors, especially brain-derived neurotrophic factor (BDNF), to maintain their synapses and survive. BDNF binds to a receptor called TrkB, activating internal signaling cascades that promote synaptic plasticity, memory consolidation, and neuronal survival. Both BDNF and TrkB are reduced in aging brains and even more so in Alzheimer’s patients.¹⁸

When TrkB levels are experimentally reduced in Alzheimer’s mouse models, the downstream signaling proteins that consolidate memories, like the transcription factor CREB, drop even further than they would from amyloid-beta alone. This means a neuron that is already under siege from amyloid toxicity loses its best biochemical tool for fighting back and repairing connections.¹⁹ The loss of neurotrophic support is not just a consequence of the disease; it amplifies every other communication breakdown, making each insult harder for the neuron to weather.

Blood Vessel Signaling and the Neurovascular Unit

The brain’s communication infrastructure extends beyond neurons and glia to include the blood vessels that supply oxygen and glucose. Neurons, astrocytes, and the cells lining blood vessels (endothelial cells and pericytes) form what researchers call the neurovascular unit, and they communicate constantly. When neurons fire more in a given region, nearby blood vessels dilate to deliver more blood, a coupling that underpins functional brain imaging techniques like fMRI.

In Alzheimer’s, pericytes, the contractile cells that wrap around capillaries, are a particularly vulnerable link. A signaling loop between endothelial cells and pericytes keeps the blood-brain barrier intact and regulates blood flow at the capillary level. When this loop breaks down, pericytes dysfunction contributes to barrier leakage, reduced blood flow, and possibly even initiates aspects of Alzheimer’s degeneration independently of amyloid.²⁰ A leaky blood-brain barrier allows inflammatory molecules from the bloodstream into the brain, compounding the neuroinflammation already driven by microglia. And reduced capillary flow starves neurons of fuel precisely when they need it most to maintain their connections.

The Gut-Brain Axis

One of the more unexpected dimensions of cell communication in Alzheimer’s involves signals that originate far from the brain. The gut harbors trillions of bacteria that produce metabolites, neurotransmitters, and immune signals capable of reaching the brain through the bloodstream and the vagus nerve. In Alzheimer’s patients, the composition of this gut microbiome is often shifted, a state called dysbiosis.

Dysbiosis has been linked to changes in blood-brain barrier integrity, neurotransmitter regulation, and, perhaps most importantly, the behavior of microglia in the brain.²¹ Gut bacteria can influence microglial activation through metabolites like short-chain fatty acids and through indirect effects on systemic inflammation. When the gut microbiome is unbalanced, these disruptions may accelerate the onset and progression of Alzheimer’s-related neuroinflammation.²² This research is still in its early stages, and no gut-targeted therapy has proven effective against Alzheimer’s in clinical trials. But the finding underscores that the brain’s communication failures are not sealed off from the rest of the body.

Selective Loss of Inhibitory Interneurons

Not all neurons are equally vulnerable. The brain depends on a balance between excitatory neurons, which push signals forward, and inhibitory interneurons, which suppress or sculpt activity to keep circuits precise. A particular class of inhibitory cells that produce the signaling molecule somatostatin appears selectively lost in the temporal cortex of Alzheimer’s patients, while other interneuron types, like those producing parvalbumin, remain relatively intact.²³

Somatostatin interneurons are critical for filtering noise, gating sensory input, and coordinating the rhythmic oscillations that synchronize distant brain regions during memory tasks. Losing them does not merely reduce inhibition; it destabilizes entire circuits, making neural activity more erratic and less tunable. This selective vulnerability may help explain symptoms that go beyond forgetting, including the heightened agitation, disrupted sleep patterns, and even the increased seizure risk seen in some Alzheimer’s patients. It also highlights that Alzheimer’s is not simply a disease of “less signal.” It is a disease of disordered signal, where the brain’s editing machinery fails alongside its broadcasting machinery.